Diamyd Medical Financials
| DMYD-B Stock | SEK 8.38 0.21 2.44% |
Diamyd |
Understanding current and past Diamyd Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Diamyd Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Diamyd Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Diamyd Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Diamyd Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Diamyd Medical's management manipulating its earnings.
Diamyd Medical Stock Summary
Diamyd Medical competes with Saniona AB, and Mendus AB. Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. Diamyd Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0005162880 |
| Business Address | Kungsgatan 29, Stockholm, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.diamyd.com |
| Phone | 46 86 61 00 26 |
| Currency | SEK - Swedish Kronor |
You should never invest in Diamyd Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Diamyd Stock, because this is throwing your money away. Analyzing the key information contained in Diamyd Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Diamyd Medical Key Financial Ratios
Diamyd Medical's financial ratios allow both analysts and investors to convert raw data from Diamyd Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Diamyd Medical over time and compare it to other companies across industries.Diamyd Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Diamyd Medical's current stock value. Our valuation model uses many indicators to compare Diamyd Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diamyd Medical competition to find correlations between indicators driving Diamyd Medical's intrinsic value. More Info.Diamyd Medical AB is rated # 3 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Diamyd Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Diamyd Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Diamyd Medical AB Systematic Risk
Diamyd Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Diamyd Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Diamyd Medical AB correlated with the market. If Beta is less than 0 Diamyd Medical generally moves in the opposite direction as compared to the market. If Diamyd Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Diamyd Medical AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Diamyd Medical is generally in the same direction as the market. If Beta > 1 Diamyd Medical moves generally in the same direction as, but more than the movement of the benchmark.
Diamyd Medical March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Diamyd Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Diamyd Medical AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Diamyd Medical AB based on widely used predictive technical indicators. In general, we focus on analyzing Diamyd Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Diamyd Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 42.66 | |||
| Value At Risk | (5.20) | |||
| Potential Upside | 3.92 |
Complementary Tools for Diamyd Stock analysis
When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |